The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
about
Non-natural and photo-reactive amino acids as biochemical probes of immune functionPAX 8 regulates human WT1 transcription through a novel DNA binding siteWT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosisWNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesisThe pleural mesothelium in development and diseasePleural mesothelial cells in pleural and lung diseasesAsbestos and mesothelioma: genetic lessons from a tragedy.Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.Prognostic significance of WT1 expression in soft tissue sarcoma.Requirement of WT1 for gonad and adrenal development: insights from transgenic animals.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease.G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.Immunotherapy for leukemia targeting the Wilms' tumor gene.Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumorGenetic profile of acute myeloid leukemia.Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesotheliomaWilms' tumour: connecting tumorigenesis and organ development in the kidney.Cancer immunotherapy targeting Wilms' tumor gene WT1 product.WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias.Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Krüppel protein.Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factorsSp1 is a critical regulator of the Wilms' tumor-1 gene.Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.Diagnostic molecular biomarkers for malignant pleural effusions.T cell-based targeted immunotherapies for patients with multiple myeloma.Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein.Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.Wilms' tumor: a paradigm for insights into development and cancer.Transcriptional activation of c-myc proto-oncogene by WT1 protein.Mesothelioma in childhood.Wilms' tumor gene expression by normal and malignant human B lymphocytes.Molecular genetics of Wilms' tumour.Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers.Transcriptional silencer of the Wilms' tumor gene WT1 contains an Alu repeat.
P2860
Q21144124-42FA56E4-F803-4B69-B2AE-6FED6098DAC8Q24310556-678EE875-AF98-408A-80BE-5A8C0EC6F3DBQ24313596-35A1A77D-B1CA-4372-9C85-92C0A3139F42Q24320196-4B9A1D77-BBD1-4391-957C-5A9CB8751EC9Q28391520-8742F738-622C-4DDF-B18B-3EECA660817DQ28396403-B9C48BC1-94B6-4B0A-823F-B3DB8DAC625DQ30530827-97835E47-849D-45A2-9AD5-4AB2E12519A8Q33635997-934CD0CA-999D-4B68-8839-1F90DAC91E42Q33738528-47927329-5C09-476A-B93E-D1AE895C0655Q33965010-EEC26DAB-ED0E-401B-B71B-82D1AD68BF0CQ34150371-541CB5A1-D480-44E1-AA05-063591C813B3Q34279672-09FBBF89-DEC6-4AB8-B954-79C874E1670DQ34329963-E057F460-2A3B-4816-9A0E-861646E8E2E3Q34341142-86D4FA8A-9B89-47EA-9E60-8BA8C22A07FCQ34431555-08C5CE1B-D6BF-4654-94C4-19B3BFD65C54Q34639436-AD8CDA1E-C33F-4B0E-AEFD-20594334C127Q34676847-ED0BF4CD-A328-4F11-8C32-1CDD4F25DA9CQ34680927-C8E50B6C-6DDE-4A2A-AA90-95E7BCC0E414Q35796277-61DF94E2-1DC2-42C3-85E1-B46BCED10184Q36234726-DFAADAD1-D2D8-4AB9-AB3C-293BEBA65865Q36238704-CEAD7283-14FF-48E3-8C95-EA3304CA9BF0Q36269963-DED2A87E-288F-4A72-8602-4126505D9D7BQ36655046-45E212C6-B882-43E9-B89B-4D200642B75EQ36828498-D7FBCD19-65CE-4C76-AD89-FB1B90054D2EQ36843618-3398E490-8B08-44DC-8E46-7834E6738EBCQ37026759-F8A804A2-852F-46EA-B85E-F4435C5146E4Q37731720-32582077-2843-427D-8C72-EFCA000E0730Q37889963-9FB22566-42C7-4722-8756-9C48524506FDQ38246639-06DADEF7-3670-4F37-A622-3AF15D026C67Q38326365-3256CFA4-83EB-42DB-A00A-E1749722EDAFQ39336282-CF3D6637-94F5-4179-BDE5-2F7F60DBCC4FQ40228775-0B2B0A2A-DF9D-4640-B2C5-297B8033E208Q40419419-042B872F-81E7-4414-A151-CF99CC8224DEQ40456138-7572AD6E-44DA-4793-9A1F-2C69C2904D86Q40529835-72410692-8090-4425-B08E-7C83BFD1BFC1Q40573623-8E5ABFAF-BCD9-485A-B994-4E02EA2B8AD6Q40859630-09FAE2AA-2D82-40BA-AA1A-8BE9E7B07BFEQ40941771-E537CF63-1E2B-4090-B724-90AE9E9E5923Q41118413-005D46CE-CFB4-414A-968B-8E49DDB7FBF6Q41323263-435641DA-C020-4D2E-B463-6AC3A479957A
P2860
The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
The Wilms tumour gene WT1 is e ...... tated in a human mesothelioma.
@en
type
label
The Wilms tumour gene WT1 is e ...... tated in a human mesothelioma.
@en
prefLabel
The Wilms tumour gene WT1 is e ...... tated in a human mesothelioma.
@en
P2093
P2860
P356
P1433
P1476
The Wilms tumour gene WT1 is e ...... tated in a human mesothelioma.
@en
P2093
Fletcher J
Maheswaran S
Rheinwald J
Schalling M
Shipley GC
P2860
P2888
P304
P356
10.1038/NG0893-415
P407
P577
1993-08-01T00:00:00Z